Hologic, Inc. (NASDAQ:HOLX)went up by 0.98% from its latest closing price when compared to the 1-year high value of $52.19 and move down -5.33%, while HOLX stocks collected +1.85% of gains with the last five trading sessions. Press Release reported on 09/04/19 that Hologic to Webcast Presentation at the Morgan Stanley 17(th) Annual Global Healthcare Conference
Hologic, Inc. (NASDAQ:HOLX) Worth an Investment?
Hologic, Inc. (NASDAQ: HOLX) The 36 Months beta value for HOLX stocks is at 0.78, while of the analysts out of 0 who provided ratings for Hologic, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $53.09 which is $3.47 above current price. HOLX currently has a short float of 1.72% and public float of 265.08M with average trading volume of 1.67M shares.
HOLX Market Performance
HOLX stocks went up by 1.85% for the week, with the monthly drop of -0.04% and a quarterly performance of 2.91%, while its annual performance rate touched 27.74%. The simple moving average for the period of the last 20 days is 0.41% for HOLX stocks with the simple moving average of 7.69% for the last 200 days.
Analysts’ Opinion on Hologic, Inc. (NASDAQ:HOLX)
Many brokerage firms have already submitted their reports for HOLX stocks, with Needham repeating the rating for HOLX shares by setting it to “Buy”. The predicted price for HOLX socks in the upcoming period according to Needham is $57 based on the research report published on August 1, 2019.
Needham, on the other hand, stated in their research note that they expect to see HOLX stock at the price of $52, previously predicting the value of $50. The rating they have provided for HOLX stocks is “Buy” according to the report published on May 2, 2019.
Needham gave “Buy” rating to HOLX stocks, setting the target price at $50 in the report published on January 31, 2019.
HOLX Stocks 1.08% Far from 50 Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, Hologic, Inc. was unable to take a rebound, for now settling with -5.06% of loss for the given period.
The stock volatility was left at 1.91%, however, within the period of a single month, the volatility rate increased by 1.96%, while the shares sank at the distance of -1.55% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +2.74% upper at the present time.
In the course of the last 5 trading sessions, HOLX went up by +1.85%, which changed the moving average for the period of 200 days to the total of +19.28% of gains for the stock in comparison to the 20-day moving average settled at $49.31. In addition, Hologic, Inc. saw 20.56% in overturn over the period of a single year with a tendency to cut further gains.
HOLX Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Hologic, Inc. (HOLX), starting from Valenti Peter J. III, who sold 7,766 shares at the price of $49.14 back on Sep 03. After this action, Rushing now owns 50,353 shares of Hologic, Inc., valued at $381,621 with the latest closing price.
MACMILLAN STEPHEN P, the Chairman, President and CEO of Hologic, Inc., sold 194,396 shares at the value of $48.77 during a trade that took place back on Aug 05, which means that MACMILLAN STEPHEN P is holding 1,587,415 shares at the value of $9,481,029 based on the most recent closing price.
HOLX Stock Fundamentals
The current profitability levels are settled at +15.79 for the present operating margin and +50.88 for gross margin. The net margin for Hologic, Inc. stands at -3.46. Total capital return value is set at 8.49, while invested capital returns managed to touch -2.18. Equity return holds the value -1.30%, with -0.40% for asset returns.
Based on Hologic, Inc. (HOLX), the company’s capital structure generated 138.50 points for debt to equity in total, while total debt to capital is set at the value of 58.07. Total debt to assets is settled at the value of 46.52 with long-term debt to equity ratio rests at 113.68 and long-term debt to capital is 47.66.
EBITDA value lies at +261.40 M with total debt to EBITDA carrying the value of 3.40. The value for Enterprise to Sales is 4.82 with debt to enterprise value settled at 0.24. The receivables turnover for Hologic, Inc. is 5.78 with the total asset turnover at the value of 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.23.